Company Filing History:
Years Active: 2025
Title: The Innovations of Tarik Regad
Introduction
Tarik Regad is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on the human endothelial protein C receptor (hEPCR), which plays a crucial role in various biological processes.
Latest Patents
Tarik Regad holds a patent for "Antibodies against hEPCR." This patent describes an antibody or antigen-binding fragment that binds to hEPCR and neutralizes, reduces, or interferes with at least one activity of hEPCR. The invention includes specific criteria for the heavy chain variable region (HCVR) and light chain variable region (LCVR) of the antibody, ensuring high specificity and efficacy. He has 1 patent to his name.
Career Highlights
Tarik Regad is affiliated with Nottingham Trent University, where he contributes to research and innovation in the field of biotechnology. His academic background and research endeavors have positioned him as a key figure in his area of expertise.
Conclusion
Tarik Regad's work in developing antibodies against hEPCR showcases his innovative spirit and dedication to advancing biotechnology. His contributions are significant in understanding and potentially treating conditions related to hEPCR.